What sector does CRISPR Therapeutics AG (CRSP) operate in?
CRISPR Therapeutics AG belongs to the Healthcare sector and operates in the Biotechnology industry.
What is CRISPR Therapeutics AG (CRSP) current stock price?
As of the latest data, CRISPR Therapeutics AG stock price is $36.14, with a previous close of $34.25. CRISPR Therapeutics AG gained $1.89 in the last trading session, representing a 5.52% increase.
What is CRISPR Therapeutics AG (CRSP) current market capitalization?
CRISPR Therapeutics AG market cap is approximately 3.10 billion.
What is CRISPR Therapeutics AG (CRSP) Earnings Per Share (EPS)?
The trailing EPS is -$4.34, and the forward EPS is -$4.00.
What is CRISPR Therapeutics AG (CRSP) EBITDA?
CRISPR Therapeutics AG EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is -59.75 million.
Does CRISPR Therapeutics AG (CRSP) dividends?
No. CRISPR Therapeutics AG does not pay a dividend.
How did CRISPR Therapeutics AG (CRSP) perform in its most recent earnings report?
In the last report (December 31, 2024), CRISPR Therapeutics AG posted an EPS surprise of 62.89% and a revenue surprise of 151.23%.
When is CRISPR Therapeutics AG (CRSP) next earnings report?
CRISPR Therapeutics AG is expected to release its next earnings report on March 31, 2025.